» Articles » PMID: 28177923

Protein Calorie Malnutrition, Nutritional Intervention and Personalized Cancer Care

Overview
Journal Oncotarget
Specialty Oncology
Date 2017 Feb 9
PMID 28177923
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer patients often experience weight loss caused by protein calorie malnutrition (PCM) during the course of the disease or treatment. PCM is expressed as severe if the patient has two or more of the following characteristics: obvious significant muscle wasting, loss of subcutaneous fat; nutritional intake of <50% of recommended intake for 2 weeks or more; bedridden or otherwise significantly reduced functional capacity; weight loss of >2% in 1 week, 5% in 1 month, or 7.5% in 3 months. Cancer anorexia-cachexia syndrome (CACS) is a multifactorial condition of advanced PCM associated with underlying illness (in this case cancer) and is characterized by loss of muscle with or without loss of fat mass. Cachexia is defined as weight loss of more than 5% of body weight in 12 months or less in the presence of chronic disease. Hence with a chronic illness on board even a small amount of weight loss can open the door to cachexia. These nutritional challenges can lead to severe morbidity and mortality in cancer patients. In the clinic, the application of personalized medicine and the ability to withstand the toxic effects of anti-cancer therapies can be optimized when the patient is in nutritional homeostasis and is free of anorexia and cachexia. Routine assessment of nutritional status and appropriate intervention are essential components of the effort to alleviate effects of malnutrition on quality of life and survival of patients.

Citing Articles

Comparison of body composition changes and nutritional status after surgery between older Japanese patients with upper and lower gastrointestinal cancer.

Takano E, Aritake T, Hashimoto K, Suzuki Y, Kitagawa Y, Fujishiro K JAR Life. 2025; 14:100006.

PMID: 40046644 PMC: 11869908. DOI: 10.1016/j.jarlif.2025.100006.


Transcutaneous Electrical Acupoint Stimulation Improves Postoperative Nutrition and Promotes Early Recovery of Gastrointestinal Function in Patients with Colorectal Cancer.

Li X, Kou Z, Liu R, Zhou Z, Mei J, Yan W Comb Chem High Throughput Screen. 2025; 28(1):64-73.

PMID: 39957303 DOI: 10.2174/0113862073255619231102112544.


Pre-treatment nutrition-related indicators and the prognosis of patients with newly diagnosed epithelial ovarian cancer: an ambispective cohort study.

Wang S, Zhu J, Wu N, Wang N, Dang X, Zhao M Front Nutr. 2025; 12:1489934.

PMID: 39886546 PMC: 11774736. DOI: 10.3389/fnut.2025.1489934.


High-risk factors and predictive models for hemorrhagic chronic radiation proctitis.

Liao Z, Hu X, Hu L, Yang J Eur J Med Res. 2025; 30(1):23.

PMID: 39794778 PMC: 11724496. DOI: 10.1186/s40001-024-02266-9.


Prognostic value of the geriatric nutritional risk index in patients with non-metastatic clear cell renal cell carcinoma: a propensity score matching analysis.

Zhou H, Lv D, Cui F, Gong Q, Li J, Wen J Nutr J. 2024; 23(1):114.

PMID: 39342187 PMC: 11439280. DOI: 10.1186/s12937-024-01010-7.


References
1.
Wickham R, Rehwaldt M, Kefer C, Shott S, Abbas K, Potter C . Taste changes experienced by patients receiving chemotherapy. Oncol Nurs Forum. 1999; 26(4):697-706. View

2.
Kahl S, Malfertheiner P . Exocrine and endocrine pancreatic insufficiency after pancreatic surgery. Best Pract Res Clin Gastroenterol. 2004; 18(5):947-55. DOI: 10.1016/j.bpg.2004.06.028. View

3.
Abendstein H, Nordgren M, Boysen M, Jannert M, Silander E, Ahlner-Elmqvist M . Quality of life and head and neck cancer: a 5 year prospective study. Laryngoscope. 2005; 115(12):2183-92. DOI: 10.1097/01.MLG.0000181507.69620.14. View

4.
Gornitsky M, Shenouda G, Sultanem K, Katz H, Hier M, Black M . Double-blind randomized, placebo-controlled study of pilocarpine to salvage salivary gland function during radiotherapy of patients with head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004; 98(1):45-52. DOI: 10.1016/j.tripleo.2004.04.009. View

5.
Batista Jr M, Olivan M, Alcantara P, Sandoval R, Peres S, Neves R . Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients. Cytokine. 2012; 61(2):532-9. DOI: 10.1016/j.cyto.2012.10.023. View